One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosis

BACKGROUND: In Germany, the first case of coronavirus disease 2019 (COVID-19) was registered on 28 January 2020. By February 2021, the third wave of the pandemic began. So far, only few data are available on the SARS-CoV-2 prevalence and the clinical impact of an infection in patients with cystic fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaudszus, Anke, Pavlova, Mariya, Rasche, Marius, Baier, Michael, Moeser, Anne, Lorenz, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943512/
https://www.ncbi.nlm.nih.gov/pubmed/35331203
http://dx.doi.org/10.1186/s12890-022-01900-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943512/
https://www.ncbi.nlm.nih.gov/pubmed/35331203
http://dx.doi.org/10.1186/s12890-022-01900-8

Ejemplares similares